腱鞘炎治疗市场 - 全球行业规模,份额,趋势,机会,预测，2018-2028 年，按治疗,按症状,按地区,竞争

全球肌腱炎治疗市场预计在预测期内将出现显着增长。

这是由于骨质疏鬆症和骨质疏鬆导致的老龄化社会中骨相关损伤的发生率不断增加。 此外，对最佳和最低成本治疗的需求不断增加，以及对关节操作和物理治疗等新疗法的认识不断提高，将显着增加世界各个地区对肌腱炎治疗市场的需求。。 此外，全球范围内用于治疗骨病的医疗保健基础设施不断增加，预计也将进一步增加对肌腱炎治疗的需求，并推动市场增长到 2027 年。 保持健康生活方式的意识增强，以及人们对体育活动的渴望，预计将在预测期内进一步推动肌腱炎治疗市场的增长。 此外，肌肉和关节创伤和过度使用等运动相关伤害的增加,康復不足以及训练课程不平衡预计将增加对肌腱炎治疗的需求并推动市场增长。 根据美国国家安全委员会 (NSC) 的数据，到 2021 年，运动器材将造成近 409,000 起伤害，是体育和娱乐类中最多的。

运动相关伤害增加

导致运动损伤的体育相关活动激增，预计在预测期内将产生有利可图的增长。 运动损伤会导致软组织损伤，这可能是全球市场的主要驱动力。 越来越多的人选择体育作为职业或爱好，并在体育领域寻找工作机会。 根据弗吉尼亚大学和杜克大学运动医学专家的一项研究，跟腱病影响了 40% 到 50% 的竞技跑步者。 腱鞘炎在人群中日益流行，每 100,000 人中有 5-10 人受到影响，预计在预测期内将提振市场。 同样，越来越多寻求物理治疗和微创手术的患者预计将在预测期内推动市场增长。

人口老龄化

许多类型的慢性病影响着世界各地的人们。 在腱鞘炎中，连接肌肉和骨骼的粗纤维索被感染。 主要在老龄化社会中肌腱炎病例的增加正在增加对肌腱炎治疗的需求，预计这将在预测期内推动市场增长。 据估计，全世界每年平均报告有 3200 万例肌腱损伤。 因此，许多事故受伤的患者要求物理治疗,非处方止痛药和外科手术，进一步推动了预测期内的市场增长。 由于偏心加强是肌腱疾病的主要治疗方法，物理疗法将成为治疗肌腱炎的首选，在预测期内推动市场增长。 这些是预测期内全球肌腱炎治疗市场增长的主要驱动力。 美国每年大约有 3000 万儿童和青少年参加某种形式的有组织的运动，每年发生超过 350 万例与运动相关的伤害，这推动了对肌腱炎治疗的需求。 根据美国国家安全委员会 (NSC) 的数据，到 2021 年，运动器材将造成近 409,000 起伤害，是体育和娱乐类中最多的。

近期发展

• InGeneron Inc. 是一家临床阶段的细胞疗法和再生医学公司，它宣布 adult 于 2021 年 7 月发布了世界上第一个对肌腱修復进行全面免疫组织化学评估的结果。

可用的自定义

根据市场数据，TechSci Research 根据公司的具体需求提供定制服务。 该报告可以定制为：

公司信息

• 对其他市场参与者（最多 5 家）进行深入分析和概况分析。

内容

第 1 章概述

• 市场定义
• 市场范围
  • 目标市场
  • 研究目标年份
  • 主要市场细分

第二章研究方法论

• 调查目的
• 基线调查方法
• 主要行业合作伙伴
• 主要协会和次要信息
• 调查方法
• 数据三角测量和验证
• 假设和限制

第 3 章执行摘要

• 市场概览
• 主要市场细分概述
• 主要市场参与者概览
• 主要地区/国家概览
• 市场驱动因素,挑战和趋势概述

第 4 章 VOC（客户之声）

• 腱鞘炎患病率（按年龄组划分）
• 肌腱炎患病率（按性别分类）
• 腱鞘炎患病率（按地区）
• 常见的肌腱炎症状

第 5 章腱鞘炎治疗的全球市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按地区
  • 按公司分类（2022 年）
• 市场地图
  • 按类型
  • 按条件
  • 按地区

第六章北美腱鞘炎治疗市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按国家
• 北美：国家/地区分析
  • 美国
  • 加拿大
  • 墨西哥

第七章欧洲腱鞘炎治疗市场前景

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按国家
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 意大利
  • 西班牙

第八章亚太地区腱鞘炎治疗市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按国家
• 亚太地区：国家/地区分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳大利亚

第 9 章：南美腱鞘炎治疗市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按国家
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第10章中东和非洲肌腱炎治疗市场展望

• 市场规模和预测
  • 按金额
• 市场份额和预测
  • 按类型（治疗方法/手术方法）
  • 通过疗法（冷疗法,物理疗法,衝击波疗法）
  • 根据症状（网球肘,高尔夫球肘,投手肘,跳投膝等）
  • 按国家
• MEA：国家分析
  • 南非肌腱炎治疗市场前景
    • 市场规模和预测
      • 按金额
    • 市场份额和预测
      • 按类型
      • 按条件
  • 沙特阿拉伯肌腱炎治疗市场前景
    • 市场规模和预测
      • 按金额
    • 市场份额和预测
      • 按类型
      • 按条件
  • 阿联酋治疗腱鞘炎的市场前景
    • 市场规模和预测
      • 按金额
    • 市场份额和预测
      • 按类型
      • 按条件

第 11 章市场动态

• 主持人
• 任务

第12章市场趋势与发展

第 13 章全球腱鞘炎治疗市场 SWOT 分析

第 14 章波特的五力分析

第15章竞争格局

• Merck and Co. Inc.
• Bayer AG
• AstraZeneca Plc.
• Boehringer Ingelheim Pharmaceuticals, Inc.
• Abbott Laboratories, Inc.
• Pfizer, Inc.
• GlaxoSmithKline PLC
• Almatica Pharma, Inc.

第 16 章战略建议

Global Tendonitis Treatment Market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the increasing incidence of bone-related injuries among the aging population due to osteoporosis or weak bone. Additionally, the growing demand for the best treatment with a low cost, along with increasing awareness about new therapies such as joint manipulation and physical therapy, will significantly increase the demand for the tendonitis treatment market across different parts of the globe. Additionally, the growing improvement of healthcare infrastructure for the treatment of bone disorders across the globe is further expected to increase the demand for tendonitis treatment, thereby fuelling market growth through 2027. Besides growing awareness about maintaining a healthy lifestyle, people are looking for sports activities which will further be expected to support the tendonitis treatment market growth during the forecast period. Furthermore, an increased number of sport-related injuries due to either trauma or overuse of muscles or joints, improper rehabilitation, and imbalanced training sessions are further expected to increase the demand for tendonitis treatment, thereby supporting market growth. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Increased Number of Sport-Related Injuries

The rapid increase in sport-related activities causing sport-related injuries is expected to create lucrative growth during the forecast period. Sports injuries can cause soft tissue injuries, which can be a major market driver across the globe. The number of people choosing sports as their career or hobby and getting work opportunities in the field of sports has increased. Achilles tendinopathy affects 40% to 50% of competitive runners, according to a study by sports medicine experts from the University of Virginia and Duke University. Tendonitis is becoming more common day by day in the population, and 5-10 cases per 100,000 population get affected, which is expected to boost the market during the forecast period. Similarly, the number of patients are demanding physical therapy and minimally invasive surgeries, which will propel the market growth during the forecast period.

Stryker has launched the Citrelock Tendon Fixation Device system at the American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting, which was held from 22-25 September 2021 in Charlotte, North Carolina, US, and designed to enable fixation without causing damage to the tendon during placement.

Growing Aging Population

Different types of chronic disorders are affecting people across the globe. In Tendonitis, a thick fibrous cord that connects muscle and bone becomes infected. The growing cases of Tendonitis, majorly among the aging population, are expected to enhance the demand for tendonitis treatment and boost the market growth during the forecast period. There are an estimated 32.0 million tendon injuries reported each year on average across the globe. So, most of the patients who are injured due to accidents demand physical therapy, over-the-counter pain relievers, and surgical procedures, which will further propel the market growth during the forecast period. Eccentric strengthening is the main treatment for tendon disorders, so physical therapy is the first line of treatment for tendonitis, which will boost the market growth during the forecast period. These are the major factor in the growth of the global Tendonitis Treatment Market in the forecast period. Every year in the U.S., about 30 million children and teens participate in some form of organized sports, and more than 3.5 million injuries each year due to sports injuries will enhance the demand for tendonitis treatment. According to the National Safety Council (NSC), in 2021, exercise equipment accounted for about 409,000 injuries, the most in any category of sports and recreation.

Market Segmentation

The global tendonitis treatment market can be segmented by therapy, condition, and by region. Based on therapy, the market can be divided into Therapy and Surgery. Based on the condition, the market can be differentiated into Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global tendonitis treatment market on account of the growing demand for advanced technology for the better treatment of tendonitis injuries in the country. As per studies, annually, around 775,000 adolescents receive therapies and treatments for sports-related injuries in the U.S.

Market Players

Merck and Co. Inc., Bayer AG, AstraZeneca Plc., Boehringer Ingelheim Pharmaceuticals, Inc., Abbott Laboratories, Inc., Pfizer, Inc., GlaxoSmithKline PLC, Almatica Pharma, Inc. are some of the leading players operating in the Global Tendonitis Treatment Market.

Recent Developments

• Clinical-stage cell therapy and regenerative medicine company InGeneron Inc. announced in July 2021 that it had published results of the world's first comprehensive immunohistochemical evaluation of adult tendon repair following local injection of fresh, uncultured and undamaged autologous cells from adipose tissue (UA-ADRCs).

Report Scope

In this report, the global tendonitis treatment market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Tendonitis Treatment Market, By Therapy:

• Therapy
• Surgery

Tendonitis Treatment Market, By Condition:

• Tennis Elbow
• Golfer's Elbow
• Pitcher's Elbow
• Jumper's Knee
• Others

Tendonitis Treatment Market, By Region:

• North America
  • United States
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Tendonitis Treatment Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

• 4.1. Prevalence of Tendonitis, By Age Group
• 4.2. Prevalence of Tendonitis, By Gender
• 4.3. Prevalence of Tendonitis, By Region
• 4.4. Commonly Observed Tendonitis Conditions

5. Global Tendonitis Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Therapy v/s Surgery)
    • 5.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
  • 5.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2022)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Condition
  • 5.3.3. By Region

6. North America Tendonitis Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Therapy v/s Surgery)
    • 6.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
  • 6.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Tendonitis Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Condition
  • 6.3.2. Canada Tendonitis Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Condition
  • 6.3.3. Mexico Tendonitis Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Condition

7. Europe Tendonitis Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Therapy v/s Surgery)
    • 7.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
  • 7.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Tendonitis Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Condition
  • 7.3.2. Germany Tendonitis Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Condition
  • 7.3.3. United Kingdom Tendonitis Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Condition
  • 7.3.4. Italy Tendonitis Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Condition
  • 7.3.5. Spain Tendonitis Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Condition

8. Asia-Pacific Tendonitis Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Therapy v/s Surgery)
    • 8.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
  • 8.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Tendonitis Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Condition
  • 8.3.2. India Tendonitis Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Condition
  • 8.3.3. Japan Tendonitis Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Condition
  • 8.3.4. South Korea Tendonitis Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Condition
  • 8.3.5. Australia Tendonitis Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Condition

9. South America Tendonitis Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Therapy v/s Surgery)
    • 9.2.1.1. By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)
  • 9.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Tendonitis Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Condition
  • 9.3.2. Argentina Tendonitis Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Condition
  • 9.3.3. Colombia Tendonitis Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Condition

10. Middle East and Africa Tendonitis Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Therapy v/s Surgery)

10.2.1.1.By Therapy (Hot & Cold Therapy, Physical Therapy, Shockwave Therapy)

• 10.2.2. By Condition (Tennis Elbow, Golfer's Elbow, Pitcher's Elbow, Jumper's Knee, Others)
• 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Tendonitis Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Condition
  • 10.3.2. Saudi Arabia Tendonitis Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Condition
  • 10.3.3. UAE Tendonitis Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Condition

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

13. Global Tendonitis Treatment Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Business Overview
• 15.2. Product Offerings
• 15.3. Recent Developments
• 15.4. Financials (As Reported)
• 15.5. Key Personnel
• 15.6. SWOT Analysis
  • 15.6.1 Merck and Co. Inc.
  • 15.6.2 Bayer AG
  • 15.6.3 AstraZeneca Plc.
  • 15.6.4 Boehringer Ingelheim Pharmaceuticals, Inc.
  • 15.6.5 Abbott Laboratories, Inc.
  • 15.6.6 Pfizer, Inc.
  • 15.6.7 GlaxoSmithKline PLC
  • 15.6.8 Almatica Pharma, Inc.

16. Strategic Recommendations